Cite
MLA Citation
Anand Kumar et al.. “Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease.” Crohn's & colitis 360, vol. 2, no. 4, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100154575635.0x00000d